A living WHO guideline on drugs for covid-19
Date
2022-09
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
This living guideline by Arnav Agarwal and colleagues (BMJ 2020;370:m3379, doi:10.1136/bmj.m3379) was last updated on 22 April 2022, but the infographic contained two dosing errors: the dose of ritonavir with renal failure should have read 100 mg, not 50 mg; and the suggested regimen for remdesivir should have been 3 days, not 5-10 days. The infographic has now been corrected.
Description
CITATION: Agarwal, A. et al. 2022. A living WHO guideline on drugs for covid-19. British Medical Journal, 370. doi:10.1136/bmj.m3379
The original publication is available at https://jcp.bmj.com/
The original publication is available at https://jcp.bmj.com/
Keywords
COVID-19 (Disease) -- Prevention -- Government policy, Coronavirus infections -- Prevention, Covid-19 guidelines
Citation
Agarwal, A. et al. 2022. A living WHO guideline on drugs for covid-19. British Medical Journal, 370. doi:10.1136/bmj.m3379